A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)-Reference-Cited by-同舟云学术

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)

Published:2020-08-07 Issue:32 Volume:99 Page:e21457
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Takahashi Kenta,Ishibashi Eri,Kubo Toshio,Harada Yohei,Hayashi Hideyuki,Kano Masayuki,Shimizu Yasushi,Shirota Hidekazu,Mori Yukiko,Muto Manabu,Ishioka Chikashi,Dosaka-Akita Hirotoshi,Matsubara Hisahiro,Nishihara Hiroshi,Sueoka-Aragane Naoko,Toyooka Shinichi,Hirakawa Akihiro,Tateishi Ukihide,Miyake Satoshi,Ikeda Sadakatsu

Funder

Japan Agency for Medical Research and Development

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference27 articles.

1. Defining actionable mutations for oncology therapeutic development;Carr;Nat Rev Cancer,2016

2. The role of next-generation sequencing in precision medicine: a review of outcomes in oncology;Morash;J Pers Med,2018

3. Moving from mutation to actionability;Colombo;Am Soc Clin Oncol Educ Book,2018

4. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients;Zehir;Nat Med,2017

5. Precision oncology medicine: the clinical relevance of patient-specific biomarkers used to optimize cancer treatment;Schmidt;J Clin Pharmacol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review;Cancers;2024-05-04

2. HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study;Cancer Immunology, Immunotherapy;2023-03-10

3. CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer;iScience;2023-03

4. Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer;BMC Cancer;2023-01-23

5. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice;Acta Médica Portuguesa;2022-09-01